PaulDavidLeberMD

Psychopharmacology

Director, Neuro-Pharm Group, LLC

Dr. Leber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I provide consulting services on the testing, development and regulatory assessment of new drug products intended for use in neurology and psychiatry

New York Presbyterian Hospital (Cornell Campus)/WestchesterResidency, Psychiatry, 1974 - 1977
NYU Grossman School of MedicineResidency, Pathology-Anatomic and Clinical, 1965 - 1968
Bellevue Hospital, NYU 3rd & 4th Division MedicineInternal Medicine, Resident, 1965 - 1965
Johns Hopkins University School of MedicineInternship, Internal Medicine, 1963 - 1964
New York University School of MedicineClass of 1963, M.D. with Honors in Physiology
Hamilton CollegeAB, Chemistry, Phi Beta Kappa, 1954 - 1958

PubMed

Journal Articles

The Use of Placebo Control Groups in the Assessment of Psychiatric Drugs: An Historical Context
Leber, P, Biological Psychiatry, 2000
Slowing the Progression of Alzheimer's Disease: Methodological Issues
Leber, P, Alzheimer Disease and Associated Disorders, 1997
Observations and Suggestions on Antidementia Drug Development
Leber, P, Alzheimer Disease and Associated Disorders, 1996
Hazards of Inference: The Active Control Investigation
Leber, P, Epilepsia, 1989
The Placebo Control in Clinical Trials. (A View from the FDA)
Leber, P, Psychopharmacology Bulletin, 1986
A Micropuncture Study of the Concentration and Fate of Albumin in the Rat Nephron
Leber, P.D. and Marsh, D.J.,, Am. J. Physiology, 1970
Inactivation of Myosin by 2,4 Dinitrophenol and Protection by Adenosine Triphosphate and other Phosphate Compounds
Levy, H.M., Leber, P.D., and Ryan, E.M.,, J. Biol Chem, 1963
Join now to see all